Nearly 1000 Viewers Registered for Live Shoulder Arthroplasty Webinar Jan 9th

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today Exactech CEO Bill Petty, MD, is scheduled to moderate a live medical education webinar where nearly 1000 orthopaedic surgeons from around the world are registered to share best practices and explore new concepts in shoulder reconstruction. “New Concepts in Shoulder Arthroplasty” will air on the website VuMedi on Thursday, January 9, from 8:00 – 9:30 PM EST.

The faculty for this program includes four renowned shoulder reconstruction specialists who will share their experiences using Exactech’s Equinoxe® shoulder system to address challenges of shoulder surgery.

  • Joseph Zuckerman, MD, will present “Subscap Sparing TSA: Indications, Rationale, Technique and Pearls.”
  • Howard Routman, DO, will present “New Biomechanical Insights in Reverse Shoulders.”
  • Greg Gilot, MD, will present “Augmented Glenoid Solutions: Design Rationale & Technique Pearls.”
  • Thomas Wright, MD, will present “Total Shoulder Arthroplasty vs. Reverse: Clinical Outcomes.”

Participants in the webinar may submit questions to the panelists and share their personal experiences through a chat room environment. Surgeons interested in joining the webinar must pre-register at http://www.vumedi.com/equinoxe.

The webinar marks Exactech’s official launch of its own channel on VuMedi. The company plans to support the on-going education of orthopaedic surgeons by providing cutting-edge educational videos on hip, knee, shoulder, biologics and bone cement surgery and techniques.

“Exactech is pleased to partner with VuMedi to provide this educational opportunity for shoulder surgeons. As an orthopaedic surgeon myself, I can appreciate the convenience of VuMedi’s forum for education and exchange,” Petty said. “We at Exactech are eager to use this channel to share valuable information on the use of our implants and instrumentation to help improve outcomes for our surgeons and their patients.”

The presentations in this webinar are based on papers recently published in a special issue of the Bulletin of the Hospital for Joint Diseases, which features 19 educational manuscripts on shoulder arthroplasty. The supplement was supported through an independent educational grant from Exactech.

For information about Exactech’s other medical educational opportunities including surgical skills laboratories, visit http://www.exac.com/medical-professionals/medical-education.

About Exactech

Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com.

About VuMedi

VuMedi is the YouTube for specialist physicians. It is the largest community in the world of orthopaedic surgeons, interventional cardiologists, radiologists, neurosurgeons, dental and oral maxillofacial physicians that visit VuMedi daily to watch expert videos, interact in discussions, participate in live webinars, and receive continuing medical education credits.

An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.

Exactech, Inc.Media Contact:Priscilla Bennett, APR, 352-377-1140Director of Marketing Communications and Public Relationspriscilla.bennett@exac.comorInvestor contactsJody Phillips, 352-377-1140Chief Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins, 305-451-1888E-mail: exactech@hawkassociates.com

Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Exactech, Inc. (delisted) Charts.
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Exactech, Inc. (delisted) Charts.